EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Olfactory Neuroblastomas: An Experience of 24 Years

Deniz Tural, Ozcan Yildiz, Fatih Selcukbiricik, Mehmet Akif Ozturk, Yildiz Keles, Buge Oz, Omer Uzel, Gokhan Demir, Nil Molinas Mandel

ISRN Oncology · 2011

DOI: 10.5402/2011/451086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Oncology, 2011. Verfasst von Deniz Tural und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, 34098 Istanbul, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to evaluate clinicopathological findings and the efficacy of the treatment modalities used in patients with olfactory neuroblastomas. Study Design . Retrospective record review.

Setting

Istanbul University, Cerrahpasa Medical Faculty, medical oncology outpatient clinic. Subjects and Methods. There were 3 stage A tumors, 5 stage B and 11 stage C according to the Kadish staging system. There were 5 grade I/II and 12 grade III/IV according to the Hyams' histopathologic system. Involvement to orbita was detected in eight patients at the time of diagnosis.

Results

The median follow-up period was 23.7 months. The 5-year survival rate for the whole group was 26%. The stage A/B groups exhibited a better survival rate than the C group with 2-year survival rates being 25 versus 71% respectively ( P = .008 ). The grade I/II groups exhibited a better survival rate than the grade III/IV groups with 2-year survival rates being 50 versus 16% respectively ( P = .001 ). The group who had orbital involvement exhibited a poor survival rate than the group of patients who had no involvement of the orbital.

Conclusion

In our study, tumor stage, histopathologic grading, involvement of the orbita, brain and bone marow metastases were the statistically significant prognostic factors.

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, 34098 Istanbul, Turkey.

Zitieren

APA

Tural, D., Yildiz, O., Selcukbiricik, F., Ozturk, M. A., Keles, Y., Oz, B., Uzel, O., Demir, G., & Mandel, N. M. (2011). Olfactory Neuroblastomas: An Experience of 24 Years. ISRN Oncology. https://doi.org/10.5402/2011/451086

Vancouver

Tural D, Yildiz O, Selcukbiricik F, Ozturk MA, Keles Y, Oz B, et al. Olfactory Neuroblastomas: An Experience of 24 Years. ISRN Oncology. 2011. doi:10.5402/2011/451086

BibTeX
@article{Tural2011,
  author = {Tural, Deniz and Yildiz, Ozcan and Selcukbiricik, Fatih and Ozturk, Mehmet Akif and Keles, Yildiz and Oz, Buge and Uzel, Omer and Demir, Gokhan and Mandel, Nil Molinas},
  title = {Olfactory Neuroblastomas: An Experience of 24 Years},
  journal = {ISRN Oncology},
  year = {2011},
  doi = {10.5402/2011/451086}
}
Kostenlos starten →